Candel Therapeutics Inc (CADL) financials · $592.0M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Candel Therapeutics Inc (CADL) $592.0M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$48.3M | -$33.4M |
| Net Income | -$38.2M | -$55.2M |
| EPS (Diluted) | -$0.72 | -$1.74 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $125.2M | $106.9M |
| Current Assets | $121.4M | $103.8M |
| Cash & Equivalents | $119.7M | $102.7M |
| PP&E | $1.64M | $2.19M |
| Total Liabilities | $73.3M | $40.5M |
| Current Liabilities | $9.00M | $37.5M |
| Short-term Debt | N/A | $9.89M |
| Long-term Debt | N/A | $1.73M |
| Total Debt | N/A | $11.6M† |
| Shareholders' Equity | $51.9M | $66.3M |
| Retained Earnings | -$230.4M | -$192.2M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$38.3M | -$27.0M |
| CapEx | $587.0K | $16.0K |
| Investing Cash Flow | -$560.0K | -$16.0K |
| Financing Cash Flow | $56.1M | $94.3M |
| Net Change in Cash | $17.2M | $67.2M |
| Free Cash Flow | -$38.9M | -$27.0M |
FAQ
What is CADL P/E and revenue?
Candel Therapeutics Inc (CADL) $592.0M cap.
What is CADL revenue?
CADL income-statement cache has no revenue figure yet.
Is CADL profitable?
Candel Therapeutics Inc last cached net income is -$38.2M (FY2025).
What are CADL total assets?
Candel Therapeutics Inc last cached total assets are $125.2M (FY2025).
What is CADL free cash flow?
Candel Therapeutics Inc last cached free cash flow is -$38.9M (FY2025).
Not investment advice. Cached statements, not a live tape.